267 related articles for article (PubMed ID: 28393777)
1. Methylene blue for postcardiopulmonary bypass vasoplegic syndrome: A cohort study.
Mazzeffi M; Hammer B; Chen E; Caridi-Scheible M; Ramsay J; Paciullo C
Ann Card Anaesth; 2017; 20(2):178-181. PubMed ID: 28393777
[TBL] [Abstract][Full Text] [Related]
2. Methylene Blue for Vasoplegic Syndrome.
Booth AT; Melmer PD; Tribble B; Mehaffey JH; Tribble C
Heart Surg Forum; 2017 Oct; 20(5):E234-E238. PubMed ID: 29087290
[TBL] [Abstract][Full Text] [Related]
3. Methylene Blue for Vasoplegic Syndrome After Cardiac Operation: Early Administration Improves Survival.
Mehaffey JH; Johnston LE; Hawkins RB; Charles EJ; Yarboro L; Kern JA; Ailawadi G; Kron IL; Ghanta RK
Ann Thorac Surg; 2017 Jul; 104(1):36-41. PubMed ID: 28551045
[TBL] [Abstract][Full Text] [Related]
4. A Reminder of Methylene Blue's Effectiveness in Treating Vasoplegic Syndrome after On-Pump Cardiac Surgery.
Manghelli J; Brown L; Tadros HB; Munfakh NA
Tex Heart Inst J; 2015 Oct; 42(5):491-4. PubMed ID: 26504450
[TBL] [Abstract][Full Text] [Related]
5. Methylene blue: potential use of an antique molecule in vasoplegic syndrome during cardiac surgery.
Lenglet S; Mach F; Montecucco F
Expert Rev Cardiovasc Ther; 2011 Dec; 9(12):1519-25. PubMed ID: 22103871
[TBL] [Abstract][Full Text] [Related]
6. Methylene Blue Monotherapy Compared With Combination Therapy With Hydroxocobalamin for the Treatment of Refractory Vasoplegic Syndrome: ARetrospective Cohort Study.
Feih JT; Rinka JRG; Zundel MT
J Cardiothorac Vasc Anesth; 2019 May; 33(5):1301-1307. PubMed ID: 30606508
[TBL] [Abstract][Full Text] [Related]
7. Methylene blue is associated with poor outcomes in vasoplegic shock.
Weiner MM; Lin HM; Danforth D; Rao S; Hosseinian L; Fischer GW
J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1233-8. PubMed ID: 23972738
[TBL] [Abstract][Full Text] [Related]
8. Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery.
Levin RL; Degrange MA; Bruno GF; Del Mazo CD; Taborda DJ; Griotti JJ; Boullon FJ
Ann Thorac Surg; 2004 Feb; 77(2):496-9. PubMed ID: 14759425
[TBL] [Abstract][Full Text] [Related]
9. Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery.
Ozal E; Kuralay E; Yildirim V; Kilic S; Bolcal C; Kücükarslan N; Günay C; Demirkilic U; Tatar H
Ann Thorac Surg; 2005 May; 79(5):1615-9. PubMed ID: 15854942
[TBL] [Abstract][Full Text] [Related]
10. Methylene Blue for Vasoplegia When on Cardiopulmonary Bypass During Double-Lung Transplantation.
Carley M; Schaff J; Lai T; Poppers J
A A Case Rep; 2015 Oct; 5(8):127-30. PubMed ID: 26466303
[TBL] [Abstract][Full Text] [Related]
11. Vasoplegic syndrome after cardiovascular surgery: A review of pathophysiology and outcome-oriented therapeutic management.
Datt V; Wadhhwa R; Sharma V; Virmani S; Minhas HS; Malik S
J Card Surg; 2021 Oct; 36(10):3749-3760. PubMed ID: 34251716
[TBL] [Abstract][Full Text] [Related]
12. Methylene blue to treat vasoplegia due to a severe protamine reaction: a case report.
Lutjen DL; Arndt KL
AANA J; 2012 Jun; 80(3):170-3. PubMed ID: 22848976
[TBL] [Abstract][Full Text] [Related]
13. Hydroxocobalamin or Methylene Blue for Vasoplegic Syndrome in Adult Cardiothoracic Surgery.
Kram SJ; Kram BL; Cook JC; Ohman KL; Ghadimi K
J Cardiothorac Vasc Anesth; 2022 Feb; 36(2):469-476. PubMed ID: 34176677
[TBL] [Abstract][Full Text] [Related]
14. Methylene Blue Does Not Improve Vasoplegia After Left Ventricular Assist Device Implantation.
Saha A; Jennings DL; Ning Y; Kurlansky P; Miltiades AN; Spellman JL; Sanchez J; Yuzefpolskaya M; Colombo PC; Takayama H; Naka Y; Takeda K
Ann Thorac Surg; 2021 Mar; 111(3):800-808. PubMed ID: 32758558
[TBL] [Abstract][Full Text] [Related]
15. Use of Intravenous Hydroxocobalamin without Methylene Blue for Refractory Vasoplegic Syndrome After Cardiopulmonary Bypass.
Peyko V; Finamore M
Am J Case Rep; 2021 Jun; 22():e930890. PubMed ID: 34143764
[TBL] [Abstract][Full Text] [Related]
16. The use of intravenous hydroxocobalamin as a rescue in methylene blue-resistant vasoplegic syndrome in cardiac surgery.
Cai Y; Mack A; Ladlie BL; Martin AK
Ann Card Anaesth; 2017; 20(4):462-464. PubMed ID: 28994688
[TBL] [Abstract][Full Text] [Related]
17. Use of methylene blue to treat vasoplegia syndrome in cystic fibrosis patients undergoing lung transplantation: A case series.
Washington GC; O'Donnell CT; Madhok J; Williams KM; Hill CC
Ann Card Anaesth; 2023; 26(1):36-41. PubMed ID: 36722586
[TBL] [Abstract][Full Text] [Related]
18. Methylene Blue as an Adjunct to Treat Vasoplegia in Patients Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass: A Literature Review.
Arevalo VN; Bullerwell ML
AANA J; 2018 Dec; 86(6):455-463. PubMed ID: 31584419
[TBL] [Abstract][Full Text] [Related]
19. The additional use of methylene blue has a decatecholaminisation effect on cardiac vasoplegic syndrome after cardiac surgery.
Petermichl W; Gruber M; Schoeller I; Allouch K; Graf BM; Zausig YA
J Cardiothorac Surg; 2021 Jul; 16(1):205. PubMed ID: 34321019
[TBL] [Abstract][Full Text] [Related]
20. Twenty years of vasoplegic syndrome treatment in heart surgery. Methylene blue revised.
Evora PR; Alves Junior L; Ferreira CA; Menardi AC; Bassetto S; Rodrigues AJ; Scorzoni Filho A; Vicente WV
Rev Bras Cir Cardiovasc; 2015; 30(1):84-92. PubMed ID: 25859872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
